Literature DB >> 16007124

deltaEF1 repressor controls selectively p53 family members during differentiation.

Giulia Fontemaggi1, Aymone Gurtner, Alexander Damalas, Antonio Costanzo, Yujiro Higashi, Ada Sacchi, Sabrina Strano, Giulia Piaggio, Giovanni Blandino.   

Abstract

The discovery of two new p53 homologs, p73 and p63, has defined a family of transcription factors heavily involved in the control of growth suppression, apoptosis, differentiation and development. While p53-deficient mice undergo spontaneous tumors, p73 and p63 knockout mice exhibit severe developmental defects. We demonstrate here that p73 gene is an in vivo transcriptional target of the muscle regulatory factors MyoD, myogenin, Myf5 and Myf6. Ectopic expression of the transcriptional repressor deltaEF1/ZEB/zfhx1a counteracts MyoD/Myf5- or MyoD/Myf6-mediated transcriptional activation of p73. A distinct pattern of in vivo recruitment of muscle regulatory factors and deltaEF1 on p73 regulatory regions was found between proliferating and differentiating muscle cells. We also found that deltaEF1 plays a role in the transcriptional regulation of p53 family members during keratinocytic differentiation. Mouse embryo fibroblasts derived from deltaEF1-deficient mice exhibit unbalanced expression of DeltaNp63, TAp73 and DeltaNp73 but not of TAp63 and p53. The analysis of tissues derived from deltaEF1+/- mice exhibit a selective enrichment of DeltaNp63 in skin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007124     DOI: 10.1038/sj.onc.1208891

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Expanding roles of ZEB factors in tumorigenesis and tumor progression.

Authors:  Ester Sánchez-Tilló; Laura Siles; Oriol de Barrios; Miriam Cuatrecasas; Eva C Vaquero; Antoni Castells; Antonio Postigo
Journal:  Am J Cancer Res       Date:  2011-08-20       Impact factor: 6.166

Review 2.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

3.  ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression.

Authors:  Laura Siles; Ester Sánchez-Tilló; Jong-Won Lim; Douglas S Darling; Kristen L Kroll; Antonio Postigo
Journal:  Mol Cell Biol       Date:  2013-01-22       Impact factor: 4.272

4.  miR-205 regulates basement membrane deposition in human prostate: implications for cancer development.

Authors:  P Gandellini; V Profumo; A Casamichele; N Fenderico; S Borrelli; G Petrovich; G Santilli; M Callari; M Colecchia; S Pozzi; M De Cesare; M Folini; R Valdagni; R Mantovani; N Zaffaroni
Journal:  Cell Death Differ       Date:  2012-05-04       Impact factor: 15.828

5.  BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma.

Authors:  Nageatte Ibrahim; Lei He; Chee-Onn Leong; Deyin Xing; Beth Y Karlan; Elizabeth M Swisher; Bo R Rueda; Sandra Orsulic; Leif W Ellisen
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

6.  The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.

Authors:  Lakshmanane Boominathan
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

7.  Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights.

Authors:  Elaine M Hurt; Jessica N Saykally; Bynthia M Anose; Kimberly R Kalli; Michel M Sanders
Journal:  Mol Cell Biochem       Date:  2008-07-12       Impact factor: 3.396

8.  Transforming growth factor β1 antagonizes the transcription, expression and vascular signaling of guanylyl cyclase/natriuretic peptide receptor A - role of δEF1.

Authors:  Anagha Sen; Prerna Kumar; Renu Garg; Sarah H Lindsey; Prasad V G Katakam; Meaghan Bloodworth; Kailash N Pandey
Journal:  FEBS J       Date:  2016-04-05       Impact factor: 5.542

9.  MiRNA-101 inhibits oral squamous-cell carcinoma growth and metastasis by targeting zinc finger E-box binding homeobox 1.

Authors:  Baolei Wu; Delin Lei; Lei Wang; Xinjie Yang; Sen Jia; Zihui Yang; Chun Shan; Xi Yang; Chenping Zhang; Bin Lu
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

Review 10.  EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.

Authors:  Ester Sánchez-Tilló; Yongqing Liu; Oriol de Barrios; Laura Siles; Lucia Fanlo; Miriam Cuatrecasas; Douglas S Darling; Douglas C Dean; Antoni Castells; Antonio Postigo
Journal:  Cell Mol Life Sci       Date:  2012-09-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.